By bringing together four leading research facilities, and co-located biopharmaceutical manufacturer, TRI will discover, produce, clinically test and manufacture new treatments and vaccines in one location – and for the first time in Australian history.

The new facility, designed by Wilson Architects and Donovan Hill in association, accommodates 650+ researchers, plus 300 additional staff across four partner institutes. According to the Architects, the interior of the space was conceived as a series of interconnected places to enable a community of research, supporting both the intensity of scientific research, and a range of opportunities for retreat and collaboration.

Consulting with the designers from an early stage, Schiavello Systems took a collaborative approach to developing furniture concepts for TRI’s work, lab, and community spaces.  After a tender process involving several rounds of prototyping for user reviews, Schiavello was engaged to deliver the furniture solution that would meet the diverse needs of TRI and its people.

Centric workstations and custom storage support the ‘write-up’ areas, work spaces near each laboratory where researchers can reflect on and record their findings.  A portion of workstations on every level are user height-adjustable, giving people the flexibility to adjust their work point based on their specific needs.

Custom moveable dividers also allow each workstation to be shortened from 1800mm to 1500mm wide to allow an additional workstation on each length of desk, providing significant flexibility for expansion into the future.  Centric, paired with System 70 panels provides a flexible, easy to use system that reticulates services in a streamlined way, and supports the custom integration of a linear lighting element created by Klik Systems.

Communal spaces feature custom Toro stools and chairs, and Toro Badjo lounges complement executive waiting and breakout spaces. Schiavello also created custom mobile laminate storage units for the labs, where solutions are required to be robust and easily cleaned.

The ability to closely collaborate with the in-house research and design team, as well as the manufacturing division in Tullamarine, allowed the project team to define the solution with the client and work rapidly through the prototyping process.

Providing a permanent home for science, the new TRI facility has been exceptionally well received, and lauded for inspiring and changing the way people work.

The Institute is a joint venture between The University of Queensland Diamantina Institute and the University of Queensland School of Medicine, Queensland University of Technology’s Institute of Health and Biomedical Innovation, Mater Research and the Princess Alexandra Hospital’s Centres for Health Research and has been made possible through $354 million in funding provided by the Australian and Queensland Governments, The Atlantic Philanthropies, UQ and QUT.